PL377265A1 - Kompozycja farmaceutyczna zawierająca prawastatynę i aspirynę - Google Patents

Kompozycja farmaceutyczna zawierająca prawastatynę i aspirynę

Info

Publication number
PL377265A1
PL377265A1 PL377265A PL37726503A PL377265A1 PL 377265 A1 PL377265 A1 PL 377265A1 PL 377265 A PL377265 A PL 377265A PL 37726503 A PL37726503 A PL 37726503A PL 377265 A1 PL377265 A1 PL 377265A1
Authority
PL
Poland
Prior art keywords
aspirin
pravastatin
layer containing
tablet containing
multilayered tablet
Prior art date
Application number
PL377265A
Other languages
English (en)
Other versions
PL206190B1 (pl
Inventor
Loutfy Benkerrour
Olivier Galley
Francoise Quinet
Admassu Abebe
Peter Timmins
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32505946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL377265(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of PL377265A1 publication Critical patent/PL377265A1/pl
Publication of PL206190B1 publication Critical patent/PL206190B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL377265A 2002-12-11 2003-12-03 Kompozycja farmaceutyczna zawierająca prawastatynę i aspirynę PL206190B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/316,424 US20040115265A1 (en) 2002-12-11 2002-12-11 Multilayered tablet containing pravastatin and aspirin and method

Publications (2)

Publication Number Publication Date
PL377265A1 true PL377265A1 (pl) 2006-01-23
PL206190B1 PL206190B1 (pl) 2010-07-30

Family

ID=32505946

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377265A PL206190B1 (pl) 2002-12-11 2003-12-03 Kompozycja farmaceutyczna zawierająca prawastatynę i aspirynę

Country Status (17)

Country Link
US (1) US20040115265A1 (pl)
EP (1) EP1581194B1 (pl)
JP (1) JP2006511520A (pl)
AT (1) ATE401061T1 (pl)
AU (1) AU2003297689A1 (pl)
CY (1) CY1108414T1 (pl)
DE (1) DE60322264D1 (pl)
DK (1) DK1581194T3 (pl)
ES (1) ES2308040T3 (pl)
IS (1) IS2877B (pl)
MY (1) MY140947A (pl)
NO (1) NO338696B1 (pl)
PL (1) PL206190B1 (pl)
PT (1) PT1581194E (pl)
SI (1) SI1581194T1 (pl)
TW (1) TWI361700B (pl)
WO (1) WO2004052289A2 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE034290T2 (en) 2003-04-29 2018-02-28 Orexigen Therapeutics Inc Preparations containing opioid antagonist and bupropion to affect weight loss
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
US20060251722A1 (en) * 2005-05-03 2006-11-09 Novavax, Inc. Multi-component vitamin and mineral supplement for the optimal absorption of components
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
CA2630624C (en) 2005-11-22 2013-08-06 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
WO2007072060A2 (en) * 2005-12-23 2007-06-28 Cipla Limited Particles comprising a core containing a hmg-coa reductase inhibitor and coated with a film
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
US8765178B2 (en) * 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
TWI609702B (zh) * 2006-11-09 2018-01-01 歐瑞根治療有限公司 層狀醫藥調配物
KR20170077291A (ko) 2006-11-09 2017-07-05 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
EP3050568B1 (en) 2007-03-13 2020-12-02 JDS Therapeutics, LLC Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) * 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
KR101330096B1 (ko) 2007-10-12 2013-11-15 페링 인터내셔널 센터 에스 에이 구연산, 산화 마그네슘, 중탄산칼륨 및 피코황산나트륨을 포함하는 의약품의 제조 방법, 이러한 방법에 의해 제조된 과립을 포함하는 약제학적 조성물 및 중간체
JP2011521973A (ja) 2008-05-30 2011-07-28 オレキシジェン・セラピューティクス・インコーポレーテッド 内臓脂肪の状態を処置するための方法
ES2762113T3 (es) 2010-01-11 2020-05-22 Nalpropion Pharmaceuticals Inc Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor
TR201005325A2 (tr) 2010-06-30 2012-01-23 Bi̇lgi̇ç Mahmut Atorvastatin ve aspirin içeren farmasötik formülasyonlar
KR20120068277A (ko) * 2010-12-17 2012-06-27 한미사이언스 주식회사 ＨＭＧ－ＣｏＡ 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제
CN103459099B (zh) * 2011-01-28 2015-08-26 英塔茨科技公司 与一个可移动的远程机器人相互交流
LT3730132T (lt) 2012-06-06 2022-08-25 Nalpropion Pharmaceuticals Llc Kompozicija, skirta panaudoti pacientų su didele širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde
EP2810644A1 (en) * 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
CA3014308A1 (en) 2016-02-11 2017-08-17 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
JP7109748B2 (ja) * 2018-12-11 2022-08-01 日本ジェネリック株式会社 アジルサルタンとアムロジピンベシル酸塩含有固形製剤及び固形製剤の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590183A (en) * 1985-04-22 1986-05-20 Sterling Drug Inc. Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
AP1224A (en) * 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin

Also Published As

Publication number Publication date
WO2004052289A3 (en) 2005-03-24
EP1581194B1 (en) 2008-07-16
DE60322264D1 (de) 2008-08-28
AU2003297689A1 (en) 2004-06-30
NO338696B1 (no) 2016-10-03
NO20052734D0 (no) 2005-06-07
EP1581194A4 (en) 2006-03-15
NO20052734L (no) 2005-07-07
TWI361700B (en) 2012-04-11
CY1108414T1 (el) 2014-02-12
MY140947A (en) 2010-02-12
PL206190B1 (pl) 2010-07-30
IS2877B (is) 2014-04-15
EP1581194A2 (en) 2005-10-05
ATE401061T1 (de) 2008-08-15
JP2006511520A (ja) 2006-04-06
WO2004052289A2 (en) 2004-06-24
PT1581194E (pt) 2008-09-24
DK1581194T3 (da) 2008-10-20
US20040115265A1 (en) 2004-06-17
ES2308040T3 (es) 2008-12-01
IS7889A (is) 2005-06-10
AU2003297689A8 (en) 2004-06-30
SI1581194T1 (sl) 2008-12-31
TW200505432A (en) 2005-02-16

Similar Documents

Publication Publication Date Title
MY140947A (en) Multilayered tablet containing pravastatin and aspirin and method
PE20000349A1 (es) Composicion farmaceutica que contiene una combinacion de una estatina y aspirina
AU2003251642A1 (en) Laser markable carrier unit
AU2003295370A1 (en) Gas layer formation materials
GB2422721B (en) Split barrier layer including nitrogen-containing portion and oxygen-containing portion
AR017749A1 (es) Estructura de multiples estratos
AU2003236831A1 (en) Materials containing multiple layers of vesicles
AU2003303377A1 (en) Vapor deposited titanium and titanium-nitride layers for dental devices
WO2007001337A3 (en) Coated substrates and methods for their preparation
AU2003234610A1 (en) Higher layer bonding of multiple access lines for carrier grade access
AU2002309511A1 (en) Seabed oil storage and tanker offtake system
AU2003244210A1 (en) Reduced-reflection film having low-refractive-index layer
DE69937898D1 (de) Mehrschichtige Tablette, enthaltend Rosiglitazone
AU2003285237A1 (en) Barrier layer for thick film dielectric electroluminescent displays
EP1020182A3 (en) A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
TH69755A (th) ยาเม็ดชนิดหลายชั้นซึ่งมีพราวาสเตติน และแอสไพริน และวิธี
Sowers Stroke in patients with diabetes
AU3028299A (en) Polyketone composition or multi-layer structure comprising polyketone layer
TW456362U (en) Wedging and combining structure for lateral panel of combination type packing box
AU2002227815A1 (en) Insertion layer for thick film electroluminescent displays
AU2003266636A1 (en) Laminate comprising silver layer and, formed thereon, layer for stabilizing the same
GT199800174A (es) Estructura absorbente en capas.
TW522812U (en) Structure improvement for worship tablet
AU2002354926A1 (en) Polymorph of the antihistamine norastemizole
AU2002248449A1 (en) Organic displays and devices containing oriented electronically active layers

Legal Events

Date Code Title Description
RECP Rectifications of patent specification